While scientists are continuing to study chloroquine and hydroxychloroquine as potential cure the coronavirus pandemic, concerns are being raised about the efficacy and safety of the drugs.

COVID-19 treatment: Chloroquine and hydroxychloroquine can cause heart problems

India has cleared the first list of 13 countries who will get hydroxychloroquine (HCQ), with neighbourhood getting priority. Also Read: No community transmission of coronavirus in the country yet, says health ministry Overall India will be giving hydroxychloroquine and paracetamol to 25 countries.

COVID-19: India clears first list of 13 countries for HCQ as neigbhourhood get priority

The Malaysian government has requested hydroxychloroquine from India to deal with COVID even as New Delhi gets the request from 30 countries for the drug. Hydroxychloroquine or HCQ is being called as a game-changer drug in the fight against COVID.

Malaysia requests hydroxychloroquine from India

A sizeable chunk of the 29 million doses of hydroxychloroquine bought by the US to combat the coronavirus pandemic is from India, President Donald Trump has said as he acknowledged that Prime Minister Narendra Modi was "great" when he sought his help to allow the sale of the anti-malaria drug to treat the growing number of COVID-19 patients in America.

US bought over 29 million hydroxychloroquine doses from India: Trump

India has now partially lifted the ban on the export of two key drugs, hydroxychloroquine and paracetamol. India's export of drugs will be allowed depending on the availability of stock after meeting domestic requirements and existing orders.

Coronavirus Pandemic: India partially lifts ban on hydroxychloroquine

Even as India is getting global requests for Hydroxychloroquine (HCQ), called as a gamechanger drug to deal with COVID, New Delhi has made it clear that its focus first will be for the countries in the neighbourhood and then countries "badly affected".

Neighbourhood first: India's policy on Hydroxychloroquine as Trump demands drug for US

US President Donald Trump has requested Indian Prime Minister Narendra Modi to supply hydroxychloroquine tablets to the US so that the drug can be used to treat COVID-19 patients.

Coronavirus: Trump requests PM Modi to supply hydroxychloroquine tablets

The US President Donald Trump requested Indian Prime Minister Narendra Modi to supply Hydroxychloroquine tablets to the United States, so that the drug can be used to treat COVID-19 patients.

US seeks India's help amid coronavirus outbreak

India has received US request for hydroxychloroquine and is looking into the request. Hydroxychloroquine is an anti-malarial drug to fight COVID-19. US President Donald Trump had on Saturday said he had requested India to release hydroxychloroquine it had ordered.

India is looking into US request for hydroxychloroquine

India has got requests from 30 countries for hydroxychloroquine, an anti-malarial drug to fight COVID-19. Several world leaders have personally raised the request with Prime Minister Narendra Modi during the recent conversation they had with him.

WION Exclusive: India gets request from 30 countries for hydroxychloroquine

ICMR has prescribed anti-malaria drug hydroxychloroquine for health workers and family members of coronavirus patients who are at high risk. US President Donald Trump says, this drug can be a game changer

WION Fineprint: Drug Hydroxychloroquine is a game changer-Trump

hydroxychloroquine

Hydroxychloroquine, News on Hydroxychloroquine, stories on Hydroxychloroquine, articles on Hydroxychloroquine, Hydroxychloroquine stories at Wion, Hydroxychloroquine news, Hydroxychloroquine latest news